Breaks Categories: News

WednesdayDec 13, 2017 9:13 am

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Executes LOI with SinglePoint, Inc. (SING)

Payment solutions company Global Payout (OTC: GOHE) this morning said that it has entered a Letter of Intent (“LOI”) with mobile technology provider SinglePoint (OTC: SING). Through this collaboration, Global Payout intends to build on its existing collection of financial technology solutions, including those used by its MoneyTrac Technology, Inc. (“MTRAC”) subsidiary. Additionally, the companies intend to examine potential technology optimization prospects that may be possible through the establishment of a joint venture. “SinglePoint’s knowledge and expertise in mobile payments and other mobile technology offerings is something we believe could be a significant addition to the financial payment platforms we…

Continue Reading

TuesdayDec 12, 2017 10:09 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Reports Key 2017 JV Achievements; Eyes Next Year’s Initiatives

SinglePoint (OTC: SING) today announced considerable growth in 2017 and success in key advances of its corporate mission with the launch of additional joint ventures and the closing of new deals within existing agreements. The company also provided a recap of 2017 achievements, as well as outlined key initiatives for 2018. Within the news release, SinglePoint president Wil Ralston stated, “Through strategic joint ventures and inside development of applications, we are pushing hard on providing a compliant solution to the cannabis industry. Our team and others have worked well in collaboration and believe we are not far away from an…

Continue Reading

TuesdayDec 12, 2017 9:55 am

NetworkNewsBreaks – PotNetwork Holding, Inc. (POTN) Completes Initial Audit Requirement to Up-List

PotNetwork Holding (OTC: POTN) today announced the successful completion of the first segment of its audit requirement for up-listing to the OTCQB, as well as long-term goal of achieving a NASDQ Capital Market listing. As part of the initial review, East West Accounting Services, LLC has satisfied compliance parameters and expects completion of the full audit by the second week of January 2018. Regarding successful completion of the initial phase, PotNetwork Holding CEO Rick Goulding stated in the news release, “We are very pleased that this segment of the process is completed.” To view the full press release, visit http://nnw.fm/WB4Hp…

Continue Reading

TuesdayDec 12, 2017 9:29 am

NetworkNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Inks LOI to Acquire Outstanding Shares of Harvest Medicine Inc.

Abcann Global (TSX.V: ABCN) (OTCQB: ABCCF) this morning said that the company recently entered into a binding Letter of Intent (“LOI”) dated December 11, 2017 to acquire all outstanding securities of Canada’s fastest growing medical cannabis clinic, Harvest Medicine Inc. Per the terms of the agreement, Abcann will make a $1,500,000 cash payment and issue 1,056,338 common shares in the capital of ABcann valued at $1,500,000, based on a deemed price of $1.42 per share. Upon the closing of the transaction, Harvest Medicine founder and CEO, Shekhar Parmar, is anticipated to join ABcann’s executive team as Chief Strategy Officer and…

Continue Reading

MondayDec 11, 2017 10:22 am

NetworkNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Provides Progress Update on California Lithium Project

Standard Lithium. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) today provided an update on the progress of its development work at the California Lithium Project, which is comprised of Mojave Desert, California area Bristol Dry Lake and Cadiz Dry Lake lithium brine properties. Progress, to date, includes installation of six new separate evaporation ponds on the Bristol Dry Lake Property designed to further assess the role of short-duration passive solar evaporation in processing the project’s lithium brines. Due to extremely high evaporation rates in the project area, previous work demonstrated the potential to concentrate brines from initial lithium concentrations of 146…

Continue Reading

MondayDec 11, 2017 9:47 am

NetworkNewsBreaks – Victory Square Technologies Inc. (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) Announces Portfolio Company, VS Blockchain Assembly Inc.

Victory Square Technologies (CSE: VST) (OTC: VSQTF) (FRANKFURT: 6F6) (WKN: A2AKL8) today introduced portfolio company, VS Blockchain Assembly Inc. Blockchain Assembly was developed to deliver blockchain and crypto advisory services to Victory Square portfolio companies. Blockchain Assembly, operating since early 2017, currently provides financial, technical, and management services to develop early-stage companies offering blockchain technology. The company also provides services to accelerate future growth through the integration and implementation of blockchain. Regarding the portfolio announcement, Shafin Diamond Tejani, chief executive officer of Victory Square said in the press release, “Recognizing that technology companies are prioritizing the integration of blockchain into…

Continue Reading

MondayDec 11, 2017 9:32 am

NetworkNewsBreaks – EVIO, Inc. (EVIO) Signs Non-Binding LOI to Acquire Licensed Cannabis Laboratory in Berkeley, CA

EVIO (OTCQB: EVIO) this morning announced that it has signed a non-binding Letter of Intent (“LOI”) to acquire 60% of C3 Labs, LLC. C3 Labs is located in Berkeley, CA, which accelerates the company’s intent to expand into Northern California prior to the anticipated increase in demand for analytical testing services. Subject to customary closing conditions, the transaction is expected to close in the first quarter of 2018. “C3 Labs been serving the cannabis industry for years, providing product formulation, research and development services that aligns with EVIO’s longer term strategy to expand our scope of services. We are working…

Continue Reading

MondayDec 11, 2017 9:03 am

NetworkNewsBreaks – Carl Data Solutions Inc.’s (CSE: CRL) (FSE: 7C5) (OTC: CDTAF) Polish Subsidiary Obtains EU Artificial Intelligence R&D Grant

Carl Data Solutions (CSE: CRL) (FSE: 7C5) (OTC: CDTAF) this morning said that its subsidiary in Poland has received a $300,000 research and development grant through the European Union (“EU”) to fund the exploration and development of artificial intelligence (“AI”) to monitor aging critical infrastructure. The company’s research will primarily focus on machine learning based AI that is able to continuously predict how anticipated storm events will impact water infrastructure, allowing the time needed for workers to protect cities from flooding and other damage. Carl Data Solutions Poland will work closely with the Department of Decision Systems and Robotics at…

Continue Reading

FridayDec 08, 2017 8:30 am

NetworkNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Retains Medical Director to Advise Cannabis Research Programs

Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning reported that the company has hired Dr. M. Scott Alexander as a medical director. Alexander’s role will be to confirm the medical integrity of cannabis research programs conducted by the company’s subsidiary, Cannevert Therapeutics Ltd. In addition, Alexander will develop a medical affairs strategy to support cannabis strains currently in development. “Dr. Alexander brings a wealth of medical knowledge, a clear understanding of current clinical practice and regulatory needs, and a pledge to educate all stakeholders about therapeutic strains that are based on Cannevert’s experimental evidence,” Veritas CEO Dr. Lui…

Continue Reading

ThursdayDec 07, 2017 2:23 pm

NetworkNewsBreaks – VistaGen Therapeutics, Inc. (NASDAQ: VTGN) Advances IP for Lead Product Candidate with New Methods of Production Patent

Clinical-stage biopharmaceutical company VistaGen Therapeutics (NASDAQ: VTGN) recently announced that it has been issued U.S. Patent No. 9,834,801 by the U.S. Patent and Trademark Office (“USPTO”), strengthening its intellectual property (“IP”) stance. The newly-issued patent covers certain methods of production for AV-101, VistaGen's lead central nervous system (“CNS”) product candidate. "This issued U.S. patent, in conjunction with the potential issuance of additional AV-101 patent applications currently under review worldwide, provides VistaGen with added long-term intellectual property protection for AV-101 and enhances its commercial potential," VistaGen CEO Shawn Singh stated in the news release. To view the full press release, visit…

Continue Reading